Skip to main content
. 2015 Aug 21;8(1):85–106. doi: 10.1002/wnan.1355

Figure 3.

Figure 3

(a) Three-dimensional MR angiogenesis maps of control and integrin-targeted fumagillin NP in Vx2 model. (b) Angiogenesis contrast before and 1 week after a fumagillin or control NPs in hyperlipidemic rabbits. (c) Decreased arthritic score and ankle thickness following targeted fumagillin in the K/BxN model of inflammatory arthritis. (Reprinted with permission from Refs 2931. Copyright 2008, 2006, and 2009)